Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion type Assertion NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_head.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion description "[In general, tubulocystic carcinoma expressed higher levels of E-cadherin and CD10, whereas collecting duct carcinoma expressed higher levels of cytokeratin 19; however, these trends did not reach statistical significance in this study cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_provenance.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion evidence source_evidence_literature NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_provenance.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion SIO_000772 19390420 NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_provenance.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion wasDerivedFrom befree-20140225 NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_provenance.
- NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_assertion wasGeneratedBy ECO_0000203 NP484937.RAveXCt3S9roX2zI-qZHPxuTAEC2CPrxv1TlmBM5Cavro130_provenance.